We have located links that may give you full text access.
Cost and Hospital Resource Utilization of Staphylococcus aureus Infection Post Elective Posterior Instrumented Spinal Fusion Surgeries in U.S. Hospitals: A Retrospective Cohort Study.
Spine 2018 October 16
STUDY DESIGN: Retrospective cohort study.
OBJECTIVE: To assess hospital resource utilization and costs associated with Staphylococcus aureus infection within 180 days post elective posterior instrumented spinal fusion surgeries (index surgery) between 2010-2015.
SUMMARY OF BACKGROUND DATA: Surgical site infections (SSIs) and blood stream infections (BSIs) post spinal fusion surgeries are associated with worse clinical outcomes and increased costs. Economic data specific to the most common pathogen of infections post spinal fusion surgeries, Staphylococcus aureus, are limited.
METHODS: We analyzed hospital discharge and microbiology data from 129 U.S. hospitals in Premier Healthcare Database. Selection criteria included: Age ≥ 18 years; had a primary/secondary ICD-9-CM procedure code for index surgery; and had microbiology data during study period. Outcomes included total hospitalization cost, length of stay and risk of all-cause readmission. Infection status was classified as culture-confirmed invasive (i.e., BSIs, deep or organ/space SSIs), any, and no Staphylococcus aureus infection. Multivariable regression analyses were used to compare outcome variables between infection groups controlling for known confounders.
RESULTS: 294 patients had any Staphylococcus aureus infection (151 had invasive infection) and 12,918 had no infection. Compared to no infection group, invasive and any infection groups had higher total hospitalization cost (Adjusted mean in 2015 U.S. dollars: $88,353 and $64,356 vs. $47,366, p-values < 0.001), longer length of stay (Adjusted mean: 20.98 and 13.15 vs. 6.77 days, p-values < 0.001), and higher risk of all-cause readmission (Adjusted risk ratio: 2.15 [95% confidence interval: 2.06, 2.25] for invasive and 1.70 [95% confidence interval: 1.61, 1.80] for any infection groups).
CONCLUSIONS: Staphylococcus aureus infections post elective posterior instrumented spinal fusion surgeries are associated with significantly higher hospitalization cost, length of stay and 180-day risk of readmission compared to those with no such infection, which presents substantial burden to hospitals and patients. Reducing such infections may cut costs and hospital resource utilization.
LEVEL OF EVIDENCE: 3This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. https://creativecommons.org/licenses/by-nc-nd/4.0.
OBJECTIVE: To assess hospital resource utilization and costs associated with Staphylococcus aureus infection within 180 days post elective posterior instrumented spinal fusion surgeries (index surgery) between 2010-2015.
SUMMARY OF BACKGROUND DATA: Surgical site infections (SSIs) and blood stream infections (BSIs) post spinal fusion surgeries are associated with worse clinical outcomes and increased costs. Economic data specific to the most common pathogen of infections post spinal fusion surgeries, Staphylococcus aureus, are limited.
METHODS: We analyzed hospital discharge and microbiology data from 129 U.S. hospitals in Premier Healthcare Database. Selection criteria included: Age ≥ 18 years; had a primary/secondary ICD-9-CM procedure code for index surgery; and had microbiology data during study period. Outcomes included total hospitalization cost, length of stay and risk of all-cause readmission. Infection status was classified as culture-confirmed invasive (i.e., BSIs, deep or organ/space SSIs), any, and no Staphylococcus aureus infection. Multivariable regression analyses were used to compare outcome variables between infection groups controlling for known confounders.
RESULTS: 294 patients had any Staphylococcus aureus infection (151 had invasive infection) and 12,918 had no infection. Compared to no infection group, invasive and any infection groups had higher total hospitalization cost (Adjusted mean in 2015 U.S. dollars: $88,353 and $64,356 vs. $47,366, p-values < 0.001), longer length of stay (Adjusted mean: 20.98 and 13.15 vs. 6.77 days, p-values < 0.001), and higher risk of all-cause readmission (Adjusted risk ratio: 2.15 [95% confidence interval: 2.06, 2.25] for invasive and 1.70 [95% confidence interval: 1.61, 1.80] for any infection groups).
CONCLUSIONS: Staphylococcus aureus infections post elective posterior instrumented spinal fusion surgeries are associated with significantly higher hospitalization cost, length of stay and 180-day risk of readmission compared to those with no such infection, which presents substantial burden to hospitals and patients. Reducing such infections may cut costs and hospital resource utilization.
LEVEL OF EVIDENCE: 3This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. https://creativecommons.org/licenses/by-nc-nd/4.0.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app